UA99259C2 - Лечение ожирения антагонистами мускаринового рецептора м1 - Google Patents
Лечение ожирения антагонистами мускаринового рецептора м1Info
- Publication number
- UA99259C2 UA99259C2 UAA200900269A UAA200900269A UA99259C2 UA 99259 C2 UA99259 C2 UA 99259C2 UA A200900269 A UAA200900269 A UA A200900269A UA A200900269 A UAA200900269 A UA A200900269A UA 99259 C2 UA99259 C2 UA 99259C2
- Authority
- UA
- Ukraine
- Prior art keywords
- mantagonist
- acetylcholine receptor
- muscarinic acetylcholine
- treating obesity
- antagonists
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 102000007207 Muscarinic M1 Receptor Human genes 0.000 title 1
- 108010008406 Muscarinic M1 Receptor Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 abstract 5
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 abstract 5
- 230000001430 anti-depressive effect Effects 0.000 abstract 2
- 239000000935 antidepressant agent Substances 0.000 abstract 2
- 229940005513 antidepressants Drugs 0.000 abstract 2
- 239000000883 anti-obesity agent Substances 0.000 abstract 1
- 229940125710 antiobesity agent Drugs 0.000 abstract 1
- 239000002830 appetite depressant Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000004584 weight gain Effects 0.000 abstract 1
- 235000019786 weight gain Nutrition 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к области медицины и касается способа содействия снижению массы тела или облегчения поддержания стабильной массы тела, который включает введение индивиду с ожирением или с чрезмерной массой тела телензепина и антидепрессанта, выбранного из группы, которая состоит из сертралина, циталопрама, эсциталопрама, венлафаксина и сибутрамина, в терапевтически эффективном количестве с целью снижения массы тела, благодаря чему активируется снижение массы тела или облегчается поддержание стабильной массы тела. Изобретение также касается фармацевтической композиции и набора.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80506606P | 2006-06-16 | 2006-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA99259C2 true UA99259C2 (ru) | 2012-08-10 |
Family
ID=40829458
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200900269A UA99259C2 (ru) | 2006-06-16 | 2007-06-15 | Лечение ожирения антагонистами мускаринового рецептора м1 |
| UAA200900268A UA98938C2 (ru) | 2006-06-16 | 2007-06-15 | Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200900268A UA98938C2 (ru) | 2006-06-16 | 2007-06-15 | Лечение психологических состояний с применением антагонистов мускариновых рецепторов м1 |
Country Status (2)
| Country | Link |
|---|---|
| CN (2) | CN101472476B (ru) |
| UA (2) | UA99259C2 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7893053B2 (en) | 2006-06-16 | 2011-02-22 | Theracos, Inc. | Treating psychological conditions using muscarinic receptor M1 antagonists |
| US8748419B2 (en) | 2006-06-16 | 2014-06-10 | Theracos, Inc. | Treating obesity with muscarinic receptor M1 antagonists |
| EP4537829A3 (en) * | 2010-10-25 | 2025-06-18 | University Of Manitoba | Therapeutic compositions for diabetic symmetrical polyneuropathy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3953430A (en) * | 1975-02-24 | 1976-04-27 | American Cyanamid Company | Substituted benzodiazepin-10-ones and method of use |
| US5668155A (en) * | 1988-05-10 | 1997-09-16 | The General Hospital Corporation | Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| EP2583675A1 (en) * | 1998-02-02 | 2013-04-24 | Trustees Of Tufts College | Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| WO2002022579A2 (en) * | 2000-09-11 | 2002-03-21 | Sepracor, Inc. | Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
| JP4175113B2 (ja) * | 2001-03-14 | 2008-11-05 | 小野薬品工業株式会社 | Ｅｐ１アンタゴニストを有効成分として含有するうつ病の治療剤 |
| US20040204472A1 (en) * | 2003-03-04 | 2004-10-14 | Pharmacia Corporation | Treatment and prevention of obesity with COX-2 inhibitors alone or in combination with weight-loss agents |
| JP2007533733A (ja) * | 2004-04-22 | 2007-11-22 | モル リサーチ アプリケーションズ リミテッド | 食物摂取管理の方法 |
-
2007
- 2007-06-15 UA UAA200900269A patent/UA99259C2/ru unknown
- 2007-06-15 CN CN200780022570.9A patent/CN101472476B/zh not_active Expired - Fee Related
- 2007-06-15 CN CN2007800224176A patent/CN101472571B/zh not_active Expired - Fee Related
- 2007-06-15 UA UAA200900268A patent/UA98938C2/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101472476A (zh) | 2009-07-01 |
| CN101472571A (zh) | 2009-07-01 |
| CN101472476B (zh) | 2013-10-30 |
| CN101472571B (zh) | 2012-11-14 |
| UA98938C2 (ru) | 2012-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009050136A3 (en) | Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome | |
| WO2008021368A3 (en) | Compositions and methods for neuroprotection | |
| WO2007123984A3 (en) | Pre-mixed, ready-to-use pharmaceutical compositions | |
| WO2007098113A3 (en) | Ccr3 inhibition for ocular angiogenesis and macular degeneration | |
| EP2425874A3 (en) | Use of a vitamin D compound and an additional therapeutic agent for the treatment of cancer | |
| WO2006015259A3 (en) | Compounds and compositions as modulators of steroid hormone nuclear receptors | |
| WO2011156518A3 (en) | Estrogen receptor modulators and uses thereof | |
| WO2004110368A3 (en) | Combination therapy for the treatment of hypertension | |
| UA106775C2 (ru) | Комбинации антагониста мускаринового ацетилхолинового рецептора и бета-2 агониста | |
| UA94909C2 (ru) | Фармацевтическая композиция нейроактивного стероида и ее применение | |
| PT2061561E (pt) | Composições para tratar o cancro | |
| WO2005070090A3 (en) | Regulatory t cells suppress autoimmunity | |
| EP3858347A3 (en) | Psma binding ligand-linker conjugates and methods for using | |
| WO2005051297A3 (en) | Combination drug therapy to treat obesity | |
| WO2007048026A3 (en) | Cgrp peptide antagonists and conjugates | |
| WO2009108720A3 (en) | Antagonists of prostaglandin d2 receptors | |
| WO2006058059A3 (en) | Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject | |
| WO2010039977A3 (en) | Heteroaryl antagonists of prostaglandin d2 receptors | |
| WO2009082038A3 (en) | Ampa receptor antagonists and zonisamide for epilepsy | |
| MY156332A (en) | Quinuclidine carbonate derivatives and medicinal composition thereof | |
| WO2009026282A3 (en) | Compositions for the treatment of stroke or cerebrovascular accidents with an endothelin b receptor agonist | |
| UA92670C2 (ru) | Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе | |
| WO2006135638A3 (en) | Tanaproget compositions containing ethinyl estradiol | |
| WO2010085820A3 (en) | Tricyclic compounds as antagonists of prostaglandin d2 receptors | |
| WO2006036770A3 (en) | Combination therapy for the treatment of obesity |